Oscar Health annual return on equity
2021
2022
2023
2024
2025
Oscar Health Return on Equity (ROE) Growth & History (OSCR)
Oscar Health's return on equity was −44.51% for fiscal 2025.
View full Oscar Health company overviewOscar Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −44.51% | −47.31 pp |
| 2024 | 2024-12-31 | 2.80% | +34.76 pp |
| 2023 | 2023-12-31 | −31.96% | +21.28 pp |
| 2022 | 2022-12-31 | −53.24% | +1200.61 pp |
| 2021 | 2021-12-31 | −1,253.85% | — |
Oscar Health quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 19.47% | +37.80 pp |
| Q1 2026 | 2026-03-31 | 51.41% | +27.95 pp |
| Q4 2025 | 2025-12-31 | −35.23% | −21.12 pp |
| Q3 2025 | 2025-09-30 | −12.60% | −7.85 pp |
| Q2 2025 | 2025-06-30 | −18.33% | −23.51 pp |
| Q1 2025 | 2025-03-31 | 23.46% | +4.14 pp |
| Q4 2024 | 2024-12-31 | −14.11% | +3.30 pp |
| Q3 2024 | 2024-09-30 | −4.75% | +2.25 pp |
| Q2 2024 | 2024-06-30 | 5.18% | +6.83 pp |
| Q1 2024 | 2024-03-31 | 19.32% | +23.69 pp |
| Q4 2023 | 2023-12-31 | −17.41% | +5.51 pp |
| Q3 2023 | 2023-09-30 | −7.00% | +9.58 pp |
| Q2 2023 | 2023-06-30 | −1.65% | +7.05 pp |
| Q1 2023 | 2023-03-31 | −4.37% | +1.16 pp |
| Q4 2022 | 2022-12-31 | −22.92% | −9.39 pp |
| Q3 2022 | 2022-09-30 | −16.58% | −3.71 pp |
| Q2 2022 | 2022-06-30 | −8.70% | −4.54 pp |
| Q1 2022 | 2022-03-31 | −5.53% | +30.73 pp |
| Q4 2021 | 2021-12-31 | −13.53% | — |
| Q3 2021 | 2021-09-30 | −12.87% | — |
| Q2 2021 | 2021-06-30 | −4.17% | — |
| Q1 2021 | 2021-03-31 | −36.25% | — |
Oscar Health return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Oscar Health's return on equity increased from −1,253.85% to −44.51%, a change of +1209.33 percentage points. The latest reported quarter, Q2 2026, shows 19.47%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oscar Health source filings ↗